Short communication: Antimicrobial efficacy of intramammary treatment with a novel biphenomycin compound against Staphylococcus aureus, Streptococcus uberis, and Escherichia coli-induced mouse mastitis

Journal of Dairy Science

Volumn 96, Issue 11, 2013, Pages 7082-7087

  Demon, Dieter ^a   Breyne, Koen ^a   Schiffer, Guido ^b   Meyer, Evelyne ^a  

^a GHENT UNIVERSITY   (Belgium)

^b AiCuris GmbH   (Germany)

Author keywords

Antimicrobial therapy; Escherichia coli; Staphylococcus aureus; Streptococcus uberis

Indexed keywords

BOS; BOVINAE; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS UBERIS;

AIC102827; ANTIINFECTIVE AGENT; CYCLOPEPTIDE;

ANIMAL; BOVINE; DISEASE MODEL; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; MASTITIS; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOUSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; UDDER; VETERINARY;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; MAMMARY GLANDS, ANIMAL; MASTITIS; MASTITIS, BOVINE; MICE; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 84886249928     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2013-7011     Document Type: Article

References (23)

1. Agirrezabala X., Frank J. Elongation in translation as a dynamic interaction among the ribosome, tRNA, and elongation factors EF-G and EF-Tu. Q. Rev. Biophys. 2009, 42:159-200.
2. Apparao M.D., Ruegg P.L., Lago A., Godden S., Bey R., Leslie K. Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium. J. Dairy Sci. 2009, 92:2589-2597.
3. Bradley A. Bovine mastitis: An evolving disease. Vet. J. 2002, 164:116-128.
4. Bramley A.J. Variations in the susceptibility of lactating and non-lactating bovine udders to infection when infused with Escherichia coli. J. Dairy Res. 1976, 43:205-211.
5. Brouillette E., Grondin G., Lefebvre C., Talbot B.G., Malouin F. Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus. Vet. Microbiol. 2004, 101:253-262.
6. Brouillette E., Malouin F. The pathogenesis and control of Staphylococcus aureus-induced mastitis: Study models in the mouse. Microbes Inf. 2005, 7:560-568.
7. CLSI. 2008, Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 3rd ed. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA.
8. Demon D., Ludwig C., Breyne K., Guede D., Dorner J.C., Froyman R., Meyer E. The intramammary efficacy of first-generation cephalosporins against Staphylococcus aureus mastitis in mice. Vet. Microbiol. 2012, 160:141-150.
9. Ezaki M., Iwami M., Yamashita M., Hashimoto S., Komori T., Umehara K., Mine Y., Kohsaka M., Aoki H., Imanaka H. Biphenomycins A and B, novel peptide antibiotics. I. Taxonomy, fermentation, isolation and characterization. J. Antibiot. (Tokyo) 1985, 38:1453-1461.
10. Gehring R., Smith G.W. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. J. Vet. Pharmacol. Ther. 2006, 29:237-241.
11. Hogeveen H., Kamphuis C., Steeneveld W., Mollenhorst H. Sensors and clinical mastitis-The quest for the perfect alert. Sensors (Basel) 2010, 10:7991-8009.
12. McDonald T.J., McDonald J.S. Streptococci isolated from bovine intramammary infections. Am. J. Vet. Res. 1976, 37:377-381.
13. NMC (National Mastitis Council). 2006. Recommended mastitis control program; National Mastitis Council Inc., Madison, WI. Accessed May 1, 2013. http://http://www.nmconline.org/docs/NMCchecklistInt.pdf.
14. Notebaert S., Demon D., Vanden Berghe T., Vandenabeele P., Meyer E. Inflammatory mediators in Escherichia coli-induced mastitis in mice. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31:551-565.
15. Notebaert S., Meyer E. Mouse models to study the pathogenesis and control of bovine mastitis. A review. Vet. Q. 2006, 28:2-13.
16. Piepers S., De Meulemeester L., de Kruif A., Opsomer G., Barkema H.W., De Vliegher S. Prevalence and distribution of mastitis pathogens in subclinically infected dairy cows in Flanders, Belgium. J. Dairy Res. 2007, 74:478-483.
17. Pinzón-Sánchez C., Cabrera V.E., Ruegg P.L. Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation. J. Dairy Sci. 2011, 94:1873-1892.
18. Prasad L.B., Newbould F.H. Inoculation of the bovine teat duct with Staph. aureus: The relationship of teat duct length, milk yield and milking rate to development of intramammary infection. Can. Vet. J. 1968, 9:107-115.
19. Pyörälä S. Treatment of mastitis during lactation. Ir. Vet. J. 2009, 62(Suppl. 4):S40-S44.
20. Saini V., McClure J.T., Leger D., Keefe G.P., Scholl D.T., Morck D.W., Barkema H.W. Antimicrobial resistance profiles of common mastitis pathogens on Canadian dairy farms. J. Dairy Sci. 2012, 95:4319-4332.
21. Van Bambeke F., Barcia-Macay M., Lemaire S., Tulkens P.M. Cellular pharmacodynamics and pharmacokinetics of antibiotics: Current views and perspectives. Curr. Opin. Drug Discov. Devel. 2006, 9:218-230.
22. Zadoks, R. 2007. Sources and epidemiology of Streptococcus uberis, with special emphasis on mastitis in dairy cattle. CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources. Vol. 2. CAB International, Wallingford, UK.
23. Zadoks R.N., Middleton J.R., McDougall S., Katholm J., Schukken Y.H. Molecular epidemiology of mastitis pathogens of dairy cattle and comparative relevance to humans. J. Mammary Gland Biol. Neoplasia 2011, 16:357-372.